Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience

Background: Nephron-sparing surgery represents the gold standard treatment for organ-confined renal tumors. We present 15-years of outcomes after off-clamp laparoscopic partial nephrectomy (ocLPN). Methods: a retrospective analysis was performed on patients who underwent ocLPN between May 2001 and D...

Full description

Bibliographic Details
Main Authors: Aldo Brassetti, Umberto Anceschi, Alfredo Maria Bove, Francesco Prata, Manuela Costantini, Mariaconsiglia Ferriero, Riccardo Mastroianni, Leonardo Misuraca, Gabriele Tuderti, Giulia Torregiani, Marco Covotta, Michele Gallucci, Giuseppe Simone
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/30/1/92
_version_ 1827626936155766784
author Aldo Brassetti
Umberto Anceschi
Alfredo Maria Bove
Francesco Prata
Manuela Costantini
Mariaconsiglia Ferriero
Riccardo Mastroianni
Leonardo Misuraca
Gabriele Tuderti
Giulia Torregiani
Marco Covotta
Michele Gallucci
Giuseppe Simone
author_facet Aldo Brassetti
Umberto Anceschi
Alfredo Maria Bove
Francesco Prata
Manuela Costantini
Mariaconsiglia Ferriero
Riccardo Mastroianni
Leonardo Misuraca
Gabriele Tuderti
Giulia Torregiani
Marco Covotta
Michele Gallucci
Giuseppe Simone
author_sort Aldo Brassetti
collection DOAJ
description Background: Nephron-sparing surgery represents the gold standard treatment for organ-confined renal tumors. We present 15-years of outcomes after off-clamp laparoscopic partial nephrectomy (ocLPN). Methods: a retrospective analysis was performed on patients who underwent ocLPN between May 2001 and December 2005. Baseline demographic, clinical, pathologic, surgical, functional and survival data were collected. The Kaplan–Meier method evaluated group-specific oncologic outcomes at 5, 10 and 15 years and the log rank test assessed differences between groups. The same analysis investigated the probabilities of developing a significant renal function impairment (sRFI) and achieving <i>ROMeS</i>. Cox analyses identified predictors of this latter tricomposite outcome. Results: We included 63 patients whose median tumor size was 3 cm (IQR:2–4). At 15 years, the chances of developing local recurrence, metachronous renal cancers or distant metastases were 2 ± 2%, 23 ± 6% and 17 ± 5%, respectively. Consequently, disease-free, cancer-specific and overall-survival probabilities were 68 ± 6%, 90 ± 4% and 72 ± 6%. MCRSS and UCISS well predicted oncologic outcomes. Overall, nine (14%) patients experienced an sRFI and 33 (52%) achieved <i>ROMeS</i>. Age (HR: 1.046; <i>p</i> = 0.033) and malignant histology (low-risk cancers HR: 3.233, <i>p</i> = 0.048) (intermediate/high risk cancers HR: 5.721, <i>p</i> = 0.023) were independent predictors of <i>ROMeS</i> non-achievement. Conclusions: At 15 years from ocLPN, most of patients will experience both excellent functional and oncologic outcomes.
first_indexed 2024-03-09T13:04:33Z
format Article
id doaj.art-32d95e8d07b142debc94e1ea8a2a2e0b
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T13:04:33Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-32d95e8d07b142debc94e1ea8a2a2e0b2023-11-30T21:50:09ZengMDPI AGCurrent Oncology1198-00521718-77292023-01-013011196120510.3390/curroncol30010092Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center ExperienceAldo Brassetti0Umberto Anceschi1Alfredo Maria Bove2Francesco Prata3Manuela Costantini4Mariaconsiglia Ferriero5Riccardo Mastroianni6Leonardo Misuraca7Gabriele Tuderti8Giulia Torregiani9Marco Covotta10Michele Gallucci11Giuseppe Simone12Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Anesthesiology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Anesthesiology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyDepartment of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, ItalyBackground: Nephron-sparing surgery represents the gold standard treatment for organ-confined renal tumors. We present 15-years of outcomes after off-clamp laparoscopic partial nephrectomy (ocLPN). Methods: a retrospective analysis was performed on patients who underwent ocLPN between May 2001 and December 2005. Baseline demographic, clinical, pathologic, surgical, functional and survival data were collected. The Kaplan–Meier method evaluated group-specific oncologic outcomes at 5, 10 and 15 years and the log rank test assessed differences between groups. The same analysis investigated the probabilities of developing a significant renal function impairment (sRFI) and achieving <i>ROMeS</i>. Cox analyses identified predictors of this latter tricomposite outcome. Results: We included 63 patients whose median tumor size was 3 cm (IQR:2–4). At 15 years, the chances of developing local recurrence, metachronous renal cancers or distant metastases were 2 ± 2%, 23 ± 6% and 17 ± 5%, respectively. Consequently, disease-free, cancer-specific and overall-survival probabilities were 68 ± 6%, 90 ± 4% and 72 ± 6%. MCRSS and UCISS well predicted oncologic outcomes. Overall, nine (14%) patients experienced an sRFI and 33 (52%) achieved <i>ROMeS</i>. Age (HR: 1.046; <i>p</i> = 0.033) and malignant histology (low-risk cancers HR: 3.233, <i>p</i> = 0.048) (intermediate/high risk cancers HR: 5.721, <i>p</i> = 0.023) were independent predictors of <i>ROMeS</i> non-achievement. Conclusions: At 15 years from ocLPN, most of patients will experience both excellent functional and oncologic outcomes.https://www.mdpi.com/1718-7729/30/1/92laparoscopylong term outcomespartial nephrectomyrenal cancersurvival
spellingShingle Aldo Brassetti
Umberto Anceschi
Alfredo Maria Bove
Francesco Prata
Manuela Costantini
Mariaconsiglia Ferriero
Riccardo Mastroianni
Leonardo Misuraca
Gabriele Tuderti
Giulia Torregiani
Marco Covotta
Michele Gallucci
Giuseppe Simone
Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
Current Oncology
laparoscopy
long term outcomes
partial nephrectomy
renal cancer
survival
title Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
title_full Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
title_fullStr Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
title_full_unstemmed Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
title_short Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience
title_sort purely off clamp laparoscopic partial nephrectomy stands the test of time 15 years functional and oncologic outcomes from a single center experience
topic laparoscopy
long term outcomes
partial nephrectomy
renal cancer
survival
url https://www.mdpi.com/1718-7729/30/1/92
work_keys_str_mv AT aldobrassetti purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT umbertoanceschi purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT alfredomariabove purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT francescoprata purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT manuelacostantini purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT mariaconsigliaferriero purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT riccardomastroianni purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT leonardomisuraca purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT gabrieletuderti purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT giuliatorregiani purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT marcocovotta purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT michelegallucci purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience
AT giuseppesimone purelyoffclamplaparoscopicpartialnephrectomystandsthetestoftime15yearsfunctionalandoncologicoutcomesfromasinglecenterexperience